ECMO启动后早期PaCO2变化与神经系统并发症相关
该多中心回顾性队列研究纳入11,972例因呼吸衰竭接受ECMO的成人患者,评估ECMO启动后24小时内PaCO2相对变化与神经系统并发症的关系。结果显示,PaCO2相对下降幅度大(>50%)者神经系统并发症发生率更高(9.8% vs. 6.4%,P < 0.001),且大幅下降是神经系统并发症的独立危险因素(OR 1.7,95%CI 1.3–2.3,P < 0.001)。
要点
- ECMO启动后24小时内PaCO2相对下降>50%与神经系统并发症风险独立相关。
- 神经系统并发症总体发生率6.9%,其中颅内出血3.5%、缺血性卒中1.9%、癫痫1.1%、脑死亡1.6%。
- 启动ECMO时应关注PaCO2下降幅度,避免大幅快速纠正。
核心结论
- 因呼吸衰竭接受ECMO的患者中,启动后24小时内PaCO2相对下降幅度大与神经系统并发症发生率增加独立相关。
研究设计与样本
- 多中心、国际、回顾性队列研究,使用体外生命支持组织注册数据库,纳入2012至2017年因呼吸衰竭接受任何模式ECMO的成人患者,共11,972例,其中88%为静脉-静脉ECMO。
主要发现
- PaCO2相对变化中位数为-31%(四分位距-46%至-12%)。
- 神经系统并发症总体发生率为6.9%,其中癫痫1.1%、缺血性卒中1.9%、颅内出血3.5%、脑死亡1.6%。
- PaCO2相对下降>50%者神经系统并发症发生率为9.8%,低于此幅度者为6.4%(P < 0.001)。
- 控制既往已描述的危险因素后,PaCO2大幅相对下降与神经系统并发症独立相关(OR 1.7,95%CI 1.3–2.3,P < 0.001)。
临床怎么用
- 在呼吸衰竭患者启动ECMO时,应监测并控制PaCO2的下降幅度,避免24小时内相对下降超过50%,以降低神经系统并发症风险。
局限性
- 本研究为回顾性队列研究,可能存在未测量的混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Large decreases in PaCO2 that occur when initiating extracorporeal membrane oxygenation (ECMO) in patients with respiratory failure may cause cerebral vasoconstriction and compromise brain tissue perfusion.Objectives: To determine if the magnitude of PaCO2 correction upon ECMO initiation is associated with an increased incidence of neurological complications in patients with respiratory failure.Methods: We conducted a multicenter, international, retrospective cohort study using the Extracorporeal Life Support Organization Registry, including adults with respiratory failure receiving ECMO via any mode between 2012 and 2017. The relative change in PaCO2 in the first 24 hours was calculated as (24-h post-ECMO PaCO2 - pre-ECMO PaCO2)/pre-ECMO PaCO2. The primary outcome was the occurrence of neurological complications, defined as seizures, ischemic stroke, intracranial hemorrhage, or brain death.Measurements and Main Results: We included 11,972 patients, 88% of whom were supported with venovenous ECMO. The median relative change in PaCO2 was -31% (interquartile range, -46% to -12%). Neurological complications were uncommon overall (6.9%), with a low incidence of seizures (1.1%), ischemic stroke (1.9%), intracranial hemorrhage (3.5%), and brain death (1.6%). Patients with a large relative decrease in PaCO2 (>50%) had an increased incidence of neurological complications compared with those with a smaller decrease (9.8% vs. 6.4%; P < 0.001). A large relative decrease in PaCO2 was independently associated with neurological complications after controlling for previously described risk factors (odds ratio, 1.7; 95% confidence interval, 1.3 to 2.3; P < 0.001).Conclusions: In patients receiving ECMO for respiratory failure, a large relative decrease in PaCO2 in the first 24 hours after ECMO initiation is independently associated with an increased incidence of neurological complications.
引用
- Cavayas YA, Munshi L, Del Sorbo L, et al. The Early Change in PaCO2 after Extracorporeal Membrane Oxygenation Initiation Is Associated with Neurological Complications. Am J Respir Crit Care Med. 2020. PMID: 32251606. doi:10.1164/rccm.202001-0023OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。